Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 2,848 | 2,665 | 1,791 | 2,515 | 2,186 |
| Operating Income | -2,848 | -2,665 | -1,791 | -2,515 | -2,186 |
| Other Income | 99 | 78 | 223 | 225 | -166 |
| Pre-tax Income | -2,749 | -2,587 | -1,568 | -2,290 | -2,352 |
| Net Income Continuous | -2,749 | -2,587 | -1,568 | -2,290 | -2,352 |
| Net Income | $-2,749 | $-2,587 | $-1,568 | $-2,290 | $-2,352 |
| EPS Basic Total Ops | -0.14 | -0.14 | -0.09 | -0.15 | -0.15 |
| EPS Basic Continuous Ops | -0.14 | -0.14 | -0.09 | -0.15 | -0.15 |
| EPS Diluted Total Ops | -0.14 | -0.14 | -0.09 | -0.15 | -0.15 |
| EPS Diluted Continuous Ops | -0.14 | -0.14 | -0.09 | -0.15 | -0.15 |
| EBITDA(a) | $-2,848 | $-2,665 | $-1,791 | $-2,515 | $-2,186 |